Haseeb Al-Mufti, MD
Nephrology · San Leandro
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 4 carriers
- Office
- 1
- Since medical school
- 50 years
- Graduated 1976
Offices
1 location
Hospitals listed: 552629 · Eden Medical Center. That is not proof they admit you there this week.
Plans that list them
17 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Al-Mufti’s office at (510) 604-6012 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A37195 · Current
Licensed to practise in California · since 1981 · expires 2028-09-30 · University of Baghdad College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$106,691
Medicare paid this office $106,691 for 66 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $97,157 | $308 |
| Return visit (30+ min) | 32 | $7,171 | $109 |
Who their Medicare patients are
66 Original Medicare patients in 2024. Average age 71 · Women 46% · Also on Medicaid 59% · Health risk score 5.06. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75% · Heart failure 48% · Coronary heart disease 39% · Atrial fibrillation 26% · COPD 21% · Stroke 18% · Depression 17%.
The office billed $206,213, Medicare allowed $137,980 and paid $106,691; for 396 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 66 | 396 | 71 | 5.06 | $206,213 | $106,691 |
| 2023 | 83 | 441 | 69 | 5.60 | $226,412 | $116,945 |
| 2022 | 128 | 764 | 71 | 5.48 | $322,420 | $166,600 |
| 2021 | 204 | 1,265 | 71 | 4.60 | $422,380 | $219,784 |
| 2020 | 168 | 1,108 | 71 | 5.02 | $396,121 | $177,416 |
| 2019 | 217 | 1,272 | 71 | 5.95 | $473,784 | $207,988 |
| 2018 | 201 | 1,482 | 72 | 5.43 | $503,977 | $222,411 |
| 2017 | 249 | 1,798 | 71 | 5.28 | $565,141 | $247,136 |
| 2016 | 263 | 1,877 | 71 | 5.13 | $611,132 | $264,584 |
| 2015 | 251 | 1,544 | 70 | 4.86 | $518,296 | $223,589 |
| 2014 | 242 | 1,743 | 69 | 4.97 | $541,890 | $234,639 |
| 2013 | 279 | 1,971 | 71 | 4.66 | $596,853 | $254,313 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $105,812 | $308 |
| Return visit (30+ min) | 37 | $7,881 | $100 |
2022: 5 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 48 | $140,134 | $314 |
| Return visit (30+ min) | 40 | $7,761 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $7,523 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,731 | $124 |
| Hemodialysis procedure with physician evaluation | 16 | $1,906 | $61 |
2021: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | $152,240 | $312 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 115 | $24,461 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $17,793 | $171 |
| Return visit (30+ min) | 44 | $7,913 | $103 |
| Hemodialysis procedure with physician evaluation | 46 | $6,138 | $65 |
| New patient visit (45+ min) | 15 | $2,077 | $138 |
| Short return visit (20+ min) | 12 | $986 | $76 |
2020: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 52 | $126,000 | $255 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $22,524 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $13,579 | $176 |
| Return visit (30+ min) | 39 | $6,790 | $89 |
| Hemodialysis procedure with physician evaluation | 31 | $4,749 | $67 |
| Short return visit (20+ min) | 15 | $1,152 | $64 |
2019: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $143,390 | $252 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $19,520 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $14,057 | $169 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $10,744 | $215 |
| Return visit (30+ min) | 54 | $9,318 | $89 |
| Hemodialysis procedure with physician evaluation | 41 | $7,286 | $65 |
| Short return visit (20+ min) | 23 | $1,958 | $61 |
2018: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 60 | $149,123 | $250 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $29,286 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $16,229 | $169 |
| Return visit (30+ min) | 57 | $9,622 | $88 |
| Hemodialysis procedure with physician evaluation | 41 | $9,452 | $64 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $4,959 | $216 |
| New patient visit (45+ min) | 12 | $1,622 | $135 |
| Short return visit (20+ min) | 16 | $1,436 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $588 | $35 |
2017: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $146,087 | $245 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 120 | $40,037 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $27,485 | $170 |
| Hemodialysis procedure with physician evaluation | 63 | $9,817 | $63 |
| Return visit (30+ min) | 62 | $9,425 | $83 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 27 | $9,291 | $206 |
| Short return visit (20+ min) | 28 | $1,736 | $54 |
| New patient visit (45+ min) | 12 | $1,343 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,160 | $34 |
2016: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 74 | $158,738 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 126 | $40,610 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $25,238 | $167 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $14,915 | $207 |
| Return visit (30+ min) | 67 | $12,071 | $86 |
| Hemodialysis procedure with physician evaluation | 42 | $8,554 | $62 |
| New patient visit (45+ min) | 12 | $1,617 | $135 |
| Short return visit (20+ min) | 15 | $1,109 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $942 | $34 |
2015: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $145,490 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 110 | $29,088 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $19,264 | $168 |
| Return visit (30+ min) | 74 | $12,988 | $87 |
| Hemodialysis procedure with physician evaluation | 42 | $5,978 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $4,528 | $206 |
| New patient visit (45+ min) | 17 | $2,478 | $146 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $1,073 | $34 |
| Short return visit (20+ min) | 16 | $964 | $48 |
2014: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 65 | $144,143 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 110 | $36,206 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $18,496 | $173 |
| Return visit (30+ min) | 74 | $13,938 | $83 |
| Hemodialysis procedure with physician evaluation | 42 | $9,431 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $5,433 | $209 |
| New patient visit (45+ min) | 14 | $1,919 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,161 | $89 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,007 | $32 |
| Short return visit (20+ min) | 12 | $892 | $59 |
2013: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 68 | $155,912 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 148 | $38,322 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $23,737 | $161 |
| Return visit (30+ min) | 74 | $13,947 | $86 |
| Hemodialysis procedure with physician evaluation | 45 | $8,822 | $60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 11 | $3,297 | $206 |
| New patient visit (45+ min) | 13 | $1,777 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,566 | $82 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 34 | $1,214 | $31 |
| Short return visit (20+ min) | 18 | $1,171 | $56 |
Medicaid work
$41,717 in 2024
Medicaid paid $41,717 for 262 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 262 | $41,717 |
| 2024 | 262 | 1 | 29 | $41,717 |
| 2023 | 505 | 2 | 36 | $44,696 |
| 2022 | 2,574 | 7 | 44 | $37,451 |
| 2021 | 4,047 | 7 | 46 | $48,366 |
| 2020 | 3,372 | 4 | 42 | $35,926 |
| 2019 | 4,427 | 8 | 46 | $53,095 |
| 2018 | 5,138 | 8 | 54 | $43,259 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 336 | $44,696 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 169 | $0 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 401 | $34,927 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 86 | $1,691 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 28 | $422 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $329 |
| Iron sucrose injection | 124 | $82 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 1,742 | $0 |
| Darbepoetin alfa, esrd use | 181 | $0 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 457 | $32,951 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 493 | $8,514 |
| Darbepoetin alfa, esrd use | 318 | $4,201 |
| 1ST HOSP IP/OBS HIGH 75 | 28 | $1,578 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 25 | $616 |
| Iron sucrose injection | 202 | $505 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,524 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 466 | $22,416 |
| Darbepoetin alfa, esrd use | 235 | $7,784 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 204 | $5,726 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,467 | $0 |
2019
| Darbepoetin alfa, esrd use | 681 | $25,274 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 512 | $20,347 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 121 | $3,306 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 38 | $1,578 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $1,004 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 25 | $802 |
| Iron sucrose injection | 129 | $784 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,902 | $0 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 580 | $28,648 |
| Darbepoetin alfa, esrd use | 648 | $6,292 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 432 | $5,170 |
| 1ST HOSP IP/OBS HIGH 75 | 42 | $1,239 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 85 | $685 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 17 | $677 |
| Iron sucrose injection | 90 | $548 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 3,244 | $0 |
Drugs they prescribed that Part D paid
$123,370
Pharmacies billed $123,370 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
401 generic and fewer than 11 brand-name prescriptions · $123,370 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 14 | $21,723 | $1,552 |
| Sevelamer Carbonate | 59 | $15,757 | $267 |
| Prosol | 71 | $12,544 | $177 |
| Calcitriol | 12 | $554 | $46 |
| Omeprazole | 24 | $486 | $20 |
See all 15 drugs
| Farxiga | 14 | $21,723 | $1,552 |
| Sevelamer Carbonate | 59 | $15,757 | $267 |
| Prosol | 71 | $12,544 | $177 |
| Calcitriol | 12 | $554 | $46 |
| Omeprazole | 24 | $486 | $20 |
| Furosemide | 23 | $177 | $8 |
| Amlodipine Besylate | 47 | $170 | $4 |
| Losartan | 16 | $140 | $9 |
| Hydralazine | 12 | $95 | $8 |
| Clonidine | 15 | $67 | $4 |
| Allopurinol | 12 | $60 | $5 |
| Atorvastatin | 13 | $60 | $5 |
| Metoprolol | 16 | $39 | $2 |
| Spironolactone | 11 | $35 | $3 |
| Lisinopril | 12 | $23 | $2 |
Year by year
| 2024 | 537 | 54 | None | None | $123,370 |
| 2023 | 587 | 62 | 0% (0) | 26% | $121,917 |
| 2022 | 766 | 72 | None | None | $203,972 |
| 2021 | 799 | 71 | None | None | $163,957 |
| 2020 | 917 | 73 | 1% (11) | None | $260,526 |
| 2019 | 1,268 | 85 | 1% (18) | 17% | $296,678 |
| 2018 | 1,369 | 79 | 2% (21) | None | $419,493 |
| 2017 | 1,581 | 97 | 3% (53) | None | $560,172 |
| 2016 | 1,533 | 98 | 4% (66) | 27% | $536,913 |
| 2015 | 1,605 | 100 | 5% (81) | None | $447,925 |
| 2014 | 1,628 | 93 | 6% (97) | None | $487,449 |
| 2013 | 1,859 | 103 | 5% (92) | 26% | $571,451 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Renvela | 30 | $50,125 | $1,671 |
| Sevelamer Carbonate | 58 | $19,703 | $340 |
| Prosol | 71 | $13,643 | $192 |
| Farxiga | 11 | $10,294 | $936 |
| Eliquis | 12 | $7,064 | $589 |
| Omeprazole | 19 | $925 | $49 |
| Plenamine | 13 | $847 | $65 |
| Amlodipine Besylate | 53 | $741 | $14 |
| Metoprolol | 33 | $732 | $22 |
| Losartan | 24 | $709 | $30 |
| Calcitriol | 14 | $646 | $46 |
| Hydralazine | 22 | $450 | $20 |
| Atorvastatin | 21 | $392 | $19 |
| Furosemide | 26 | $303 | $12 |
| Prednisone | 12 | $214 | $18 |
| Lisinopril | 14 | $131 | $9 |
2022: 17 drugs
| Renvela | 36 | $80,393 | $2,233 |
| Sevelamer Carbonate | 57 | $26,111 | $458 |
| Clinisol | 97 | $18,212 | $188 |
| Eliquis | 18 | $13,047 | $725 |
| Prosol | 91 | $10,950 | $120 |
| Plenamine | 51 | $3,394 | $67 |
| Calcitriol | 12 | $802 | $67 |
| Losartan | 39 | $699 | $18 |
| Metoprolol | 42 | $538 | $13 |
| Omeprazole | 12 | $460 | $38 |
| Chlorthalidone | 11 | $438 | $40 |
| Hydralazine | 21 | $288 | $14 |
| Atorvastatin | 21 | $263 | $13 |
| Amlodipine Besylate | 41 | $238 | $6 |
| Furosemide | 17 | $222 | $13 |
| Prednisone | 14 | $92 | $7 |
| Gabapentin | 11 | $61 | $6 |
2021: 16 drugs
| Renvela | 27 | $63,399 | $2,348 |
| Clinisol | 220 | $40,618 | $185 |
| Sevelamer Carbonate | 62 | $21,027 | $339 |
| Cinacalcet | 11 | $14,158 | $1,287 |
| Calcitriol | 12 | $1,053 | $88 |
| Bumetanide | 11 | $749 | $68 |
| Midodrine | 13 | $633 | $49 |
| Amlodipine Besylate | 55 | $585 | $11 |
| Omeprazole | 17 | $550 | $32 |
| Hydralazine | 17 | $467 | $27 |
| Losartan | 35 | $422 | $12 |
| Metoprolol | 46 | $346 | $8 |
| Atorvastatin | 24 | $282 | $12 |
| Carvedilol | 12 | $100 | $8 |
| Prednisone | 16 | $100 | $6 |
| Nystatin | 11 | $88 | $8 |
2020: 15 drugs
| Renvela | 37 | $105,254 | $2,845 |
| Clinisol | 316 | $56,746 | $180 |
| Sevelamer Carbonate | 54 | $17,859 | $331 |
| Prosol | 20 | $3,427 | $171 |
| Nifedipine Er | 13 | $1,597 | $123 |
| Lidocaine-Prilocaine | 14 | $830 | $59 |
| Hydralazine | 16 | $489 | $31 |
| Omeprazole | 16 | $420 | $26 |
| Amlodipine Besylate | 51 | $350 | $7 |
| Metoprolol | 12 | $340 | $28 |
| Metoprolol | 58 | $320 | $6 |
| Losartan | 24 | $202 | $8 |
| Prednisone | 18 | $151 | $8 |
| Gabapentin | 12 | $118 | $10 |
| Hydrocortisone | 12 | $86 | $7 |
2019: 27 drugs
| Renvela | 46 | $110,994 | $2,413 |
| Clinisol | 369 | $60,174 | $163 |
| Sevelamer Carbonate | 53 | $22,067 | $416 |
| Veltassa | 14 | $11,968 | $855 |
| Prosol | 52 | $8,739 | $168 |
| Nexium | 12 | $3,556 | $296 |
| Clotrimazole-Betamethasone | 11 | $2,057 | $187 |
| Midodrine | 21 | $1,293 | $62 |
| Nifedipine Er | 22 | $1,107 | $50 |
| Acetaminophen-Codeine | 12 | $712 | $59 |
| Omeprazole | 21 | $573 | $27 |
| Chlorthalidone | 15 | $472 | $31 |
| Metoprolol | 64 | $460 | $7 |
| Atorvastatin | 29 | $454 | $16 |
| Amlodipine Besylate | 54 | $380 | $7 |
| Allopurinol | 23 | $368 | $16 |
| Zolpidem | 12 | $233 | $19 |
| Losartan | 31 | $227 | $7 |
| Clonazepam | 15 | $212 | $14 |
| Prednisone | 28 | $195 | $7 |
| Carvedilol | 18 | $180 | $10 |
| Ondansetron | 13 | $168 | $13 |
| Lisinopril | 30 | $144 | $5 |
| Trazodone | 12 | $125 | $10 |
| Ranitidine | 11 | $122 | $11 |
| Furosemide | 16 | $104 | $7 |
| Simvastatin | 15 | $87 | $6 |
2018: 27 drugs
| Renvela | 62 | $158,191 | $2,551 |
| Sevelamer Carbonate | 66 | $55,415 | $840 |
| Clinisol | 325 | $53,638 | $165 |
| Velphoro | 13 | $37,739 | $2,903 |
| Sensipar | 26 | $36,277 | $1,395 |
| Januvia | 14 | $9,071 | $648 |
| Prosol | 52 | $8,114 | $156 |
| Travasol | 18 | $1,053 | $58 |
| Ventolin Hfa | 16 | $1,043 | $65 |
| Nifedipine Er | 31 | $989 | $32 |
| Acetaminophen-Codeine | 12 | $606 | $50 |
| Midodrine | 21 | $587 | $28 |
| Amlodipine Besylate | 64 | $533 | $8 |
| Atorvastatin | 37 | $438 | $12 |
| Chlorthalidone | 12 | $416 | $35 |
| Omeprazole | 35 | $357 | $10 |
| Allopurinol | 22 | $336 | $15 |
| Metoprolol | 67 | $327 | $5 |
| Hydralazine | 19 | $248 | $13 |
| Megestrol Acetate | 16 | $240 | $15 |
| Losartan | 27 | $201 | $7 |
| Furosemide | 48 | $182 | $4 |
| Ranitidine | 13 | $163 | $13 |
| Metoclopramide | 11 | $118 | $11 |
| Carvedilol | 30 | $102 | $3 |
| Prednisone | 18 | $97 | $5 |
| Lisinopril | 19 | $50 | $3 |
2017: 38 drugs
| Renvela | 132 | $251,996 | $1,909 |
| Sensipar | 105 | $145,376 | $1,385 |
| Clinisol | 252 | $38,562 | $153 |
| Renagel | 15 | $30,451 | $2,030 |
| Levemir | 12 | $9,619 | $802 |
| Humalog | 12 | $9,585 | $799 |
| Januvia | 16 | $9,379 | $586 |
| Prosol | 34 | $5,167 | $152 |
| Ventolin Hfa | 27 | $1,874 | $69 |
| Novolin N | 13 | $1,801 | $139 |
| Travasol | 24 | $1,587 | $66 |
| Nifedipine Er | 37 | $1,273 | $34 |
| Hydrocodone-Acetaminophen | 40 | $1,153 | $29 |
| Acetaminophen-Codeine | 13 | $872 | $67 |
| Atorvastatin | 45 | $569 | $13 |
| Amlodipine Besylate | 69 | $531 | $8 |
| Labetalol | 17 | $528 | $31 |
| Metoprolol | 76 | $388 | $5 |
| Allopurinol | 20 | $338 | $17 |
| Zolpidem | 13 | $313 | $24 |
| Omeprazole | 34 | $303 | $9 |
| Midodrine | 13 | $269 | $21 |
| Furosemide | 61 | $239 | $4 |
| Megestrol Acetate | 18 | $211 | $12 |
| Spironolactone | 16 | $191 | $12 |
| Hydralazine | 14 | $179 | $13 |
| Losartan | 33 | $176 | $5 |
| Loperamide | 11 | $152 | $14 |
| Ranitidine | 11 | $147 | $13 |
| Warfarin | 20 | $133 | $7 |
| Famotidine | 18 | $97 | $5 |
| Clonidine | 12 | $94 | $8 |
| Carvedilol | 32 | $90 | $3 |
| Pantoprazole | 12 | $78 | $6 |
| Lisinopril | 19 | $70 | $4 |
| Sertraline | 11 | $57 | $5 |
| Metoclopramide | 13 | $53 | $4 |
| Simvastatin | 14 | $35 | $2 |
2016: 36 drugs
| Renvela | 113 | $251,269 | $2,224 |
| Sensipar | 130 | $159,859 | $1,230 |
| Clinisol | 219 | $31,193 | $142 |
| Levemir | 11 | $8,872 | $807 |
| Humalog | 12 | $8,848 | $737 |
| Hydrocodone-Acetaminophen | 52 | $1,839 | $35 |
| Warfarin | 48 | $1,076 | $22 |
| Acetaminophen-Codeine | 13 | $1,038 | $80 |
| Ventolin Hfa | 17 | $921 | $54 |
| Omeprazole | 46 | $717 | $16 |
| Nifedipine Er | 15 | $650 | $43 |
| Metoprolol | 83 | $572 | $7 |
| Metoprolol | 15 | $571 | $38 |
| Atorvastatin | 40 | $508 | $13 |
| Zolpidem | 16 | $481 | $30 |
| Allopurinol | 26 | $474 | $18 |
| Minoxidil | 19 | $441 | $23 |
| Amlodipine Besylate | 82 | $439 | $5 |
| Hydralazine | 13 | $316 | $24 |
| Lidocaine-Prilocaine | 18 | $312 | $17 |
| Gabapentin | 11 | $237 | $22 |
| Carvedilol | 35 | $233 | $7 |
| Clonidine | 26 | $216 | $8 |
| Cephalexin | 13 | $178 | $14 |
| Spironolactone | 17 | $167 | $10 |
| Losartan | 25 | $163 | $7 |
| Valsartan-Hydrochlorothiazide | 12 | $162 | $13 |
| Lisinopril | 45 | $144 | $3 |
| Ranitidine | 13 | $132 | $10 |
| Furosemide | 23 | $130 | $6 |
| Megestrol Acetate | 12 | $127 | $11 |
| Clonazepam | 12 | $123 | $10 |
| Isosorbide Mononitrate Er | 16 | $113 | $7 |
| Pantoprazole | 11 | $93 | $8 |
| Simvastatin | 22 | $58 | $3 |
| Famotidine | 18 | $58 | $3 |
2015: 38 drugs
| Renvela | 137 | $229,364 | $1,674 |
| Sensipar | 78 | $90,381 | $1,159 |
| Renagel | 12 | $23,253 | $1,938 |
| Clinisol | 180 | $22,709 | $126 |
| Levemir | 18 | $10,794 | $600 |
| Novolog | 19 | $10,384 | $547 |
| Telmisartan | 15 | $3,049 | $203 |
| Hydrocodone-Acetaminophen | 69 | $2,006 | $29 |
| Omeprazole | 51 | $770 | $15 |
| Warfarin | 48 | $765 | $16 |
| Acetaminophen-Codeine | 12 | $653 | $54 |
| Nifedipine Er | 15 | $637 | $42 |
| Metoprolol | 16 | $633 | $40 |
| Metoprolol | 103 | $631 | $6 |
| Amlodipine Besylate | 104 | $537 | $5 |
| Atorvastatin | 40 | $504 | $13 |
| Nystatin | 13 | $454 | $35 |
| Minoxidil | 27 | $443 | $16 |
| Allopurinol | 30 | $425 | $14 |
| Clonidine | 41 | $378 | $9 |
| Carvedilol | 35 | $285 | $8 |
| Megestrol Acetate | 26 | $284 | $11 |
| Gabapentin | 19 | $282 | $15 |
| Hydralazine | 14 | $175 | $12 |
| Spironolactone | 17 | $172 | $10 |
| Isosorbide Mononitrate Er | 20 | $158 | $8 |
| Cephalexin | 15 | $131 | $9 |
| Furosemide | 22 | $124 | $6 |
| Ranitidine | 18 | $106 | $6 |
| Simvastatin | 17 | $98 | $6 |
| Clonazepam | 15 | $98 | $7 |
| Lisinopril | 21 | $87 | $4 |
| Losartan | 11 | $83 | $8 |
| Azithromycin | 11 | $76 | $7 |
| Prednisone | 14 | $75 | $5 |
| Famotidine | 25 | $69 | $3 |
| Fluoxetine | 11 | $45 | $4 |
| Glipizide | 17 | $43 | $3 |
2014: 39 drugs
| Renvela | 99 | $134,160 | $1,355 |
| Sensipar | 80 | $71,369 | $892 |
| Sevelamer Carbonate | 27 | $39,210 | $1,452 |
| Clinisol | 178 | $24,400 | $137 |
| Renagel | 11 | $17,218 | $1,565 |
| Tacrolimus | 11 | $7,441 | $676 |
| Nexium | 13 | $5,559 | $428 |
| Januvia | 12 | $3,600 | $300 |
| Hydrocodone-Acetaminophen | 81 | $1,841 | $23 |
| Minoxidil | 67 | $1,322 | $20 |
| Metoprolol | 18 | $1,295 | $72 |
| Nifedical Xl | 11 | $1,127 | $102 |
| Omeprazole | 44 | $795 | $18 |
| Amlodipine Besylate | 75 | $668 | $9 |
| Acetaminophen-Codeine | 15 | $665 | $44 |
| Metoprolol | 96 | $586 | $6 |
| Atorvastatin | 39 | $572 | $15 |
| Labetalol | 12 | $502 | $42 |
| Clonidine | 59 | $487 | $8 |
| Clopidogrel | 12 | $417 | $35 |
| Warfarin | 32 | $407 | $13 |
| Hydralazine | 21 | $382 | $18 |
| Ranitidine | 28 | $360 | $13 |
| Megestrol Acetate | 34 | $349 | $10 |
| Nifedipine Er | 12 | $339 | $28 |
| Gabapentin | 28 | $329 | $12 |
| Levothyroxine | 11 | $296 | $27 |
| Prednisone | 37 | $237 | $6 |
| Lisinopril | 33 | $227 | $7 |
| Allopurinol | 26 | $204 | $8 |
| Simvastatin | 18 | $201 | $11 |
| Cephalexin | 17 | $154 | $9 |
| Loperamide | 12 | $134 | $11 |
| Carvedilol | 14 | $115 | $8 |
| Isosorbide Mononitrate Er | 11 | $110 | $10 |
| Clonazepam | 13 | $108 | $8 |
| Famotidine | 16 | $91 | $6 |
| Glipizide | 12 | $81 | $7 |
| Fluoxetine | 11 | $57 | $5 |
2013: 37 drugs
| Renvela | 129 | $137,963 | $1,069 |
| Sensipar | 107 | $89,343 | $835 |
| Clinisol | 203 | $41,784 | $206 |
| Renagel | 29 | $30,228 | $1,042 |
| Clotrimazole-Betamethasone | 15 | $3,593 | $240 |
| Januvia | 13 | $3,284 | $253 |
| Metoprolol | 37 | $2,131 | $58 |
| Hydrocodone-Acetaminophen | 78 | $1,771 | $23 |
| Omeprazole | 48 | $1,503 | $31 |
| Clopidogrel | 11 | $1,391 | $126 |
| Minoxidil | 61 | $1,319 | $22 |
| Amlodipine Besylate | 92 | $1,116 | $12 |
| Atorvastatin | 31 | $764 | $25 |
| Hydralazine | 32 | $695 | $22 |
| Metoprolol | 103 | $649 | $6 |
| Acetaminophen-Codeine | 13 | $636 | $49 |
| Ranitidine | 24 | $635 | $26 |
| Warfarin | 39 | $622 | $16 |
| Felodipine Er | 17 | $603 | $35 |
| Labetalol | 11 | $510 | $46 |
| Losartan | 17 | $503 | $30 |
| Clonidine | 54 | $472 | $9 |
| Nifedipine Er | 13 | $459 | $35 |
| Gabapentin | 35 | $396 | $11 |
| Lisinopril | 62 | $369 | $6 |
| Megestrol Acetate | 31 | $353 | $11 |
| Simvastatin | 21 | $252 | $12 |
| Cephalexin | 21 | $184 | $9 |
| Allopurinol | 26 | $159 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $138 | $12 |
| Prednisone | 36 | $133 | $4 |
| Hydroxyzine | 11 | $131 | $12 |
| Clonazepam | 15 | $126 | $8 |
| Atenolol | 13 | $115 | $9 |
| Zolpidem | 14 | $101 | $7 |
| Loperamide | 11 | $100 | $9 |
| Furosemide | 15 | $97 | $6 |
Money from drug and device companies
$19 in 2025
| 2025 | 1 | 1 | None | $19 |
| 2022 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Benlysta | $19 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2025-02-18 | Benlysta | $19 |
See earlier years (2022)
2022: $18
| Novo Nordisk | Ozempic | $18 | 1 payment
|
Professional record
- NPI
- 1649223017
- Licence
- CA A37195California A37195: Current · expires 2028-09-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 660 4th St, Unit 349, San Francisco, CA, 94107
- NPI first listed
- 2006-05-18
- NPI last updated
- 2008-09-17
This is when the NPI record was last certified, not a medical board exam.